Literature DB >> 8785062

TrkA activation is sufficient to rescue axotomized cholinergic neurons.

C A Lucidi-Phillipi1, D O Clary, L F Reichardt, F H Gage.   

Abstract

To test the molecular nature of the NGF receptor responsible for the ability of NGF to rescue septal cholinergic neurons following axotomy, we infused polyclonal antibodies that act as specific agonists of trkA (RTA) into the lateral ventricle of fimbria-fornix lesioned animals. Rats receiving chronic intraventricular infusions of RTA showed significantly more low affinity NGF receptor immunoreactive (p75NGFR-IR) neurons on the lesioned side than did control animals 2 weeks following unilateral fimbria-fornix lesion. RTA also initiated cholinergic sprouting. Infusions of RTA in combination with an antibody that blocks p75NGFR (REX) did not reduce the cell savings effect observed with RTA alone. However, animals infused with RTA plus REX demonstrated significantly less sprouting. These findings suggest that antibody-induced trkA activation is sufficient to mediate NGF-promoted survival of axotomized cholinergic neurons in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785062      PMCID: PMC2757416          DOI: 10.1016/s0896-6273(00)80084-7

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  60 in total

1.  Morphological response of axotomized septal neurons to nerve growth factor.

Authors:  F H Gage; D M Armstrong; L R Williams; S Varon
Journal:  J Comp Neurol       Date:  1988-03-01       Impact factor: 3.215

2.  Gene transfer and molecular cloning of the rat nerve growth factor receptor.

Authors:  M J Radeke; T P Misko; C Hsu; L A Herzenberg; E M Shooter
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

3.  Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections.

Authors:  F Hefti
Journal:  J Neurosci       Date:  1986-08       Impact factor: 6.167

4.  The unbiased estimation of number and sizes of arbitrary particles using the disector.

Authors:  D C Sterio
Journal:  J Microsc       Date:  1984-05       Impact factor: 1.758

5.  Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment.

Authors:  C N Montero; F Hefti
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

6.  Nerve growth factor treatment after brain injury prevents neuronal death.

Authors:  L F Kromer
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons.

Authors:  F Hefti; J Hartikka; F Eckenstein; H Gnahn; R Heumann; M Schwab
Journal:  Neuroscience       Date:  1985-01       Impact factor: 3.590

8.  Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.

Authors:  L R Williams; S Varon; G M Peterson; K Wictorin; W Fischer; A Bjorklund; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage.

Authors:  T Hagg; M Manthorpe; H L Vahlsing; S Varon
Journal:  Exp Neurol       Date:  1988-08       Impact factor: 5.330

10.  PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor.

Authors:  S H Green; R E Rydel; J L Connolly; L A Greene
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

View more
  16 in total

1.  NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes.

Authors:  Jonah R Chan; Trent A Watkins; José M Cosgaya; ChunZhao Zhang; Lian Chen; Louis F Reichardt; Eric M Shooter; Ben A Barres
Journal:  Neuron       Date:  2004-07-22       Impact factor: 17.173

Review 2.  Signaling of neuronal cell death by the p75NTR neurotrophin receptor.

Authors:  E J Coulson; K Reid; P F Bartlett
Journal:  Mol Neurobiol       Date:  1999-08       Impact factor: 5.590

3.  Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation.

Authors:  T T Yeo; J Chua-Couzens; L L Butcher; D E Bredesen; J D Cooper; J S Valletta; W C Mobley; F M Longo
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  The mouse homeobox gene Gbx2 is required for the development of cholinergic interneurons in the striatum.

Authors:  Li Chen; Mallika Chatterjee; James Y H Li
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

5.  The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB.

Authors:  B Xu; W Gottschalk; A Chow; R I Wilson; E Schnell; K Zang; D Wang; R A Nicoll; B Lu; L F Reichardt
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

6.  Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody.

Authors:  A Cattaneo; S Capsoni; E Margotti; M Righi; E Kontsekova; P Pavlik; P Filipcik; M Novak
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

7.  Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes.

Authors:  M L Grimes; J Zhou; E C Beattie; E C Yuen; D E Hall; J S Valletta; K S Topp; J H LaVail; N W Bunnett; W C Mobley
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

8.  Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons.

Authors:  Thomas Naumann; Elisabeth Casademunt; Ewald Hollerbach; Jutta Hofmann; Georg Dechant; Michael Frotscher; Yves-Alain Barde
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

9.  TrkA activation in the rat visual cortex by antirat trkA IgG prevents the effect of monocular deprivation.

Authors:  T Pizzorusso; N Berardi; F M Rossi; A Viegi; K Venstrom; L F Reichardt; L Maffei
Journal:  Eur J Neurosci       Date:  1999-01       Impact factor: 3.386

Review 10.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.